Sunday, May 11, 2025 5/11/2025

Assessing Markey Cancer Center's Alignment with National Standards for Survivorship Care

Award Number: P30CA177558
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Description

Assessing Markey Cancer Center's Alignment with National Standards for Survivorship Care - PROJECT SUMMARY/ABSTRACT The Markey Cancer Center (MCC) is a university-based matrix cancer center at the University of Kentucky (UK) with a mission to reduce the cancer burden with a focus on Kentucky and its most vulnerable populations through research, prevention, treatment, education and community engagement. As the only National Cancer Institute (NCI)-designated Cancer Center in the state, the MCC is vital to Kentucky, the U.S. leader for highest all-site cancer incidence and mortality. Notably, recognition of the extraordinary disease burden in Kentucky’s vulnerable populations, as a significant underpinning of that national ranking, shapes the MCC vision and goals and drives its unique focus on prevalent cancers and cancer risk factors in the catchment population. Over $569M in state, institutional and philanthropic investment since 2009 has supported significant research and resource expansion, propelling new faculty recruitment, program development, clinical and shared resource space renovations, new state-of-the art instrumentation and statewide education and community outreach. MCC’s 159 members align with one of three MCC Research Programs: Cancer Prevention and Control, Molecular and Cellular Oncology and Translational Oncology, and are supported by seven Shared Resource Facilities that facilitate cutting-edge research via robust infrastructure, specialized expertise and advanced methods: Biospecimen Procurement and Translational Pathology, Biostatistics and Bioinformatics, Cancer Research Informatics, Flow Cytometry and Immune Monitoring, Oncogenomics, Patient-Oriented and Population Sciences and Redox Metabolism. Significant achievements in this funding period include an increased research depth and breadth as indicated by increased total cancer-relevant funding (41%), peer- reviewed funding (35%) and NCI funding (55%). Expanded transdisciplinary collaborations, driven in part through a strategic focus on precision medicine and a more streamlined translational pipeline, resulted in 26 new therapeutic trials, 8 concepts or devices in Phase I or II clinical trials, 10 agents or devices undergoing in vivo validation, 43 patent applications and 17 patents during the current funding period—all based on MCC science. In collaboration with other U.S. and international cancer centers, the number of U- and P-series grants awarded to the MCC increased by 80%. The number of member publications increased by 28% (total of 1,093) with 62% of the publications with cancer investigators at other institutions. Expanded education and training initiatives include a new NCI T32 focused on rural cancer health disparities, a new NCI R25 Youth Enjoy Science award to engage Appalachian students in cancer research and two new training programs emphasizing diversity, equity and inclusion. With unique research strengths and integrated statewide community outreach and engagement, MCC’s programs provide robust capacity to deliver transformative interventional research to Kentucky’s underserved populations, thereby contributing to national efforts to conquer cancer through discovery and clinical translation, cancer prevention and community outreach.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $2,774,680 )
2024	2024	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE	500 S LIMESTONE	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	006	12	8/22/2024	SUPPLEMENT FOR EXPANSION	$60,000
2024	2024	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE	500 S LIMESTONE	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	005	12	7/30/2024	NON-COMPETING CONTINUATION	$2,699,683
2024	2024	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE	500 S LIMESTONE	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	007	12	9/4/2024	SUPPLEMENT FOR EXPANSION	$100,593
2024	2023	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE	500 S LIMESTONE	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	001	11	11/13/2023	COMPETING CONTINUATION	$0
2024	2023	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE	500 S LIMESTONE	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	004	11	6/26/2024	COMPETING CONTINUATION	$632,755
2024	2022	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE	500 S LIMESTONE	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	000	10	10/1/2023	SUPPLEMENT FOR EXPANSION	-$85,596
2024	2022	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE	500 S LIMESTONE	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	003	10	6/26/2024	SUPPLEMENT FOR EXPANSION	-$245,064
2024	2022	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE	500 S LIMESTONE	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	002	10	6/26/2024	NON-COMPETING CONTINUATION	-$387,691
														Subtotal = $2,774,680

Issue Date FY: 2023 ( Subtotal = $2,699,683 )
2023	2023	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	001	11	9/5/2023	COMPETING CONTINUATION	$2,699,683
2023	2022	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	000	10	10/26/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $2,699,683

Issue Date FY: 2022 ( Subtotal = $2,397,774 )
2022	2022	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	000	10	9/3/2022	NON-COMPETING CONTINUATION	$2,152,710
2022	2022	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	001	10	9/14/2022	SUPPLEMENT FOR EXPANSION	$245,064
														Subtotal = $2,397,774

Issue Date FY: 2021 ( Subtotal = $2,551,929 )
2021	2021	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	001	9	8/16/2021	NON-COMPETING CONTINUATION	$2,152,710
2021	2021	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	003	9	9/24/2021	SUPPLEMENT FOR EXPANSION	$150,000
2021	2021	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	002	9	9/23/2021	SUPPLEMENT FOR EXPANSION	$249,219
2021	2020	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	000	8	12/7/2020	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $2,551,929

Issue Date FY: 2020 ( Subtotal = $3,142,429 )
2020	2020	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	001	8	6/30/2020	SUPPLEMENT FOR EXPANSION	$249,396
2020	2020	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	003	8	9/2/2020	SUPPLEMENT FOR EXPANSION	$99,963
2020	2020	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	004	8	9/9/2020	SUPPLEMENT FOR EXPANSION	$150,000
2020	2020	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Treatment Research	002	8	8/13/2020	SUPPLEMENT FOR EXPANSION	$299,813
2020	2020	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	000	8	6/29/2020	NON-COMPETING CONTINUATION	$2,152,710
2020	2020	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	21st Century Cures Act - Beau Biden Cancer Moonshot	005	8	9/10/2020	SUPPLEMENT FOR EXPANSION	$190,547
														Subtotal = $3,142,429

Issue Date FY: 2019 ( Subtotal = $2,725,110 )
2019	2019	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	011	7	8/2/2019	SUPPLEMENT FOR EXPANSION	$250,000
2019	2019	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	010	7	6/21/2019	NON-COMPETING CONTINUATION	$2,152,710
2019	2019	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	014	7	9/20/2019	SUPPLEMENT FOR EXPANSION	$0
2019	2019	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	013	7	9/13/2019	SUPPLEMENT FOR EXPANSION	$200,000
2019	2019	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	21st Century Cures Act - Beau Biden Cancer Moonshot	012	7	9/4/2019	SUPPLEMENT FOR EXPANSION	$122,400
2019	2018	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	007	6	1/18/2019	COMPETING CONTINUATION	$220
2019	2018	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	005	6	12/7/2018	COMPETING CONTINUATION	$692,084
2019	2018	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	000	6	10/23/2018	SUPPLEMENT FOR EXPANSION	$0
2019	2018	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	009	6	2/8/2019	COMPETING CONTINUATION	$3,423
2019	2017	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	003	5	12/7/2018	SUPPLEMENT FOR EXPANSION	-$101,773
2019	2017	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	006	5	1/18/2019	SUPPLEMENT FOR EXPANSION	-$220
2019	2017	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	002	5	12/7/2018	SUPPLEMENT FOR EXPANSION	-$241,905
2019	2017	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	001	5	12/7/2018	SUPPLEMENT FOR EXPANSION	-$94,548
2019	2017	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	008	5	2/8/2019	SUPPLEMENT FOR EXPANSION	-$3,423
2019	2017	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	21st Century Cures Act - Beau Biden Cancer Moonshot	004	5	12/7/2018	SUPPLEMENT FOR EXPANSION	-$253,858
														Subtotal = $2,725,110

Issue Date FY: 2018 ( Subtotal = $2,909,146 )
2018	2018	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	000	6	7/9/2018	COMPETING CONTINUATION	$2,152,710
2018	2018	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	21st Century Cures Act - Beau Biden Cancer Moonshot	005	6	9/12/2018	SUPPLEMENT FOR EXPANSION	$213,531
2018	2018	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	001	6	9/4/2018	SUPPLEMENT FOR EXPANSION	$101,000
2018	2018	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	002	6	9/6/2018	SUPPLEMENT FOR EXPANSION	$241,905
2018	2018	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	004	6	9/11/2018	SUPPLEMENT FOR EXPANSION	$200,000
2018	2018	UNIVERSITY OF KENTUCKY	500 S LIMESTONE 109 KINKEAD HALL	LEXINGTON	KY	40526	FAYETTE	USA	Cancer Centers Support Grants	003	6	9/6/2018	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $2,909,146

Grand Total All Awards = $30,007,591

Page 1 of 2 (87 items)12

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Assessing Markey Cancer Center's Alignment with National Standards for Survivorship Care

Award Number: P30CA177558

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer